VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NUTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NUTXNutex Health, Inc.
$187.90$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNUTXQuarterly Financials

Nutex Health, Inc. (NUTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Nutex Health, Inc. (NUTX) quarterly income statement — complete revenue, gross profit & net income history

NUTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue216.49M151.68M267.8M243.99M211.79M257.62M78.79M76.08M67.45M69.67M62.72M58.92M56.33M53.72M28.4M58.05M79.13M63.4M117.97M62.81M
Revenue Growth %2.22%-41.12%239.87%220.69%213.98%269.77%25.62%29.12%19.75%29.68%120.89%1.51%-28.81%-15.26%-75.93%-7.59%3828.19%-40.26%--
Cost of Goods Sold124.75M105.54M112.92M119.06M93.45M115.99M56.88M53.52M57.3M56.46M50.91M49.28M51.48M53.19M52.11M51.41M43.31M41.16M41.96M33.68M
COGS % of Revenue57.63%69.58%42.17%48.8%44.12%45.02%72.19%70.35%84.94%81.03%81.17%83.63%91.39%99.01%183.51%88.56%54.74%64.91%35.57%53.61%
Gross Profit91.73M46.14M154.88M124.92M118.34M141.63M21.92M22.56M10.16M13.21M11.81M9.65M4.85M530.32K-23.71M6.64M35.82M22.24M76.01M29.14M
Gross Margin %42.37%30.42%57.83%51.2%55.88%54.98%27.82%29.65%15.06%18.97%18.83%16.37%8.61%0.99%-83.51%11.44%45.26%35.09%64.43%46.39%
Gross Profit Growth %-22.48%-67.42%606.68%453.71%1065.07%971.84%85.54%133.87%109.52%2391.55%149.81%45.33%-86.46%-97.62%-131.2%-77.22%8290.22%-79.04%--
Operating Expenses14.38M15.22M24.51M91.25M46.13M27.42M12.25M17.26M8.71M39.36M12.63M10.01M9.29M-4.02M404.97M8.02M6.58M6.71M1.55M1.53M
OpEx % of Revenue6.64%10.03%9.15%37.4%21.78%10.64%15.55%22.69%12.91%56.49%20.14%16.99%16.5%-7.49%1426.19%13.81%8.31%10.58%1.31%2.44%
Selling, General & Admin14.38M17.82M11.3M12.5M10.04M27.43M11.83M10.59M8.71M9.14M7.84M10.01M9.08M6.31M6.83M4.13M6.58M1.36M1.55M1.53M
SG&A % of Revenue6.64%11.75%4.22%5.12%4.74%10.65%15.01%13.92%12.91%13.11%12.51%16.99%16.11%11.74%24.06%7.12%8.31%2.15%1.31%2.44%
Research & Development000000000000000073.75K000
R&D % of Revenue----------------0.09%---
Other Operating Expenses0-1000K1000K1000K1000K-11.64K425.22K1000K01000K1000K0217.27K-1000K1000K1000K-73.75K1000K00
Operating Income81.27M30.92M130.37M33.68M72.21M114.21M9.66M5.3M1.45M-26.14M-821.23K-362.54K-4.45M4.55M-428.68M-1.38M29.24M15.54M74.46M27.6M
Operating Margin %37.54%20.38%48.68%13.8%34.09%44.33%12.26%6.96%2.15%-37.53%-1.31%-0.62%-7.89%8.47%-1509.7%-2.37%36.95%24.51%63.12%43.95%
Operating Income Growth %12.54%-72.93%1249.17%535.57%4881.3%536.83%1276.62%1561.65%132.61%-674.28%99.81%73.7%-115.2%-70.7%-675.7%-104.99%804.57%-75.47%--
EBITDA86.76M36.1M135.37M38.93M77.3M119.49M14.64M9.83M5.64M-21.46M1.07M3.81M-451.34K7.82M-424.35M1.75M31.64M16.85M76.33M31.54M
EBITDA Margin %40.08%23.8%50.55%15.95%36.5%46.38%18.57%12.92%8.36%-30.81%1.7%6.47%-0.8%14.56%-1494.45%3.02%39.98%26.58%64.71%50.21%
EBITDA Growth %12.23%-69.78%824.96%295.93%1271.61%656.75%1272.28%157.77%1348.68%-374.3%100.25%117.46%-101.43%-53.58%-655.91%-94.44%874.47%-74.09%--
D&A (Non-Cash Add-back)5.49M5.19M5M5.25M5.09M5.28M4.97M4.53M4.19M4.68M1.89M4.18M3.99M3.27M4.33M3.13M2.4M1.32M1.87M3.94M
EBIT030.92M129.39M29.41M68.88M113.63M2.8M8.96M4.29M-26.47M-777.76K-239.01K-4.69M4.34M-428.05M24.75K26.86M19.09M76.21M31.66M
Net Interest Income0-4.98M-5.45M-5.68M-6.12M-5.05M-5.38M-5.05M-4.44M-4.24M-4.1M-4.84M-3.14M-2.86M-3.4M-4.37M-1.86M-1.94M-1.26M-1.5M
Interest Income00000000000000000000
Interest Expense4.68M4.98M5.45M5.68M6.12M5.05M5.38M5.05M4.44M4.24M4.1M4.84M3.14M2.86M3.4M4.37M1.86M1.94M1.26M1.5M
Other Income/Expense-4.71M-5.02M-6.43M-9.95M-9.45M-5.63M-12.24M-1.39M-1.6M-4.57M-4.04M-4.72M-3.39M-3.07M-2.77M-2.97M-4.24M-2.19M485.09K2.56M
Pretax Income76.56M25.89M123.94M23.73M62.76M108.58M-2.58M3.9M-152.82K-30.71M-4.87M-5.08M-7.83M1.48M-431.45M-4.34M25M13.35M74.95M30.16M
Pretax Margin %35.37%17.07%46.28%9.73%29.64%42.15%-3.27%5.13%-0.23%-44.08%-7.76%-8.62%-13.91%2.75%-1519.46%-7.49%31.6%21.05%63.53%48.01%
Income Tax13.8M9.29M27.14M7.59M18.54M8.61M4.58M893.89K389.67K-3M-342.26K-815.61K-910.66K1.81M-8.54M19.65M176.32K-126.24K453.62K481.5K
Effective Tax Rate %18.02%35.86%21.9%31.97%29.54%7.93%-177.66%22.9%-254.98%9.76%7.03%16.05%11.63%122.13%1.98%-452.33%0.71%-0.95%0.61%1.6%
Net Income46.81M11.83M55.44M-17.7M14.63M61.7M-8.79M-364.05K-364.07K-31.62M-5.54M-3.48M-5.15M-4.42M-412.19M-19.28M21.44M13.98M53.79M27.06M
Net Margin %21.62%7.8%20.7%-7.25%6.91%23.95%-11.15%-0.48%-0.54%-45.38%-8.84%-5.9%-9.14%-8.23%-1451.61%-33.22%27.1%22.05%45.6%43.08%
Net Income Growth %219.85%-80.82%730.78%-4761.17%4119.5%295.13%-58.57%89.54%92.93%-615.23%98.66%81.96%-124%-131.62%-866.24%-171.27%582.45%-65.27%--
Net Income (Continuing)46.81M16.61M96.8M16.14M44.22M99.97M-7.17M3.01M-542.49K-27.71M-4.52M-4.27M-6.92M-327.05K-422.91M-24M24.83M13.47M74.49M29.68M
Discontinued Operations00000000000000000000
Minority Interest95.76M93.99M120.87M101.63M77.77M55.55M19.34M19.29M16.99M17.65M14.98M15.61M16.92M24.46M22.04M40.72M194.75K76.93M12.34K-89.51K
EPS (Diluted)6.521.627.76-3.022.5611.12-1.72-0.07-0.08-7.50-1.25-0.79-1.11-2.17-100.04-5.45-4.193.8113.616.85
EPS Growth %154.69%-85.43%551.16%-4025.68%3332.32%248.27%-37.6%90.73%92.86%-245.62%98.75%85.5%73.51%-156.96%-835.05%-179.56%-274.11%-55.18%--
EPS (Basic)6.981.688.27-3.212.6511.83-1.72-0.07-0.08-7.86-1.25-0.98-1.27-2.35-100.04-5.48-4.193.2313.506.85
Diluted Shares Outstanding7.18M7.18M7.18M5.85M5.85M5.1M5.1M4.97M4.6M4.22M4.43M4.38M4.65M4.92M4.33M4.31M3.95M3.95M3.95M3.95M
Basic Shares Outstanding6.7M6.7M6.7M5.52M5.52M5.1M5.1M4.97M4.5M4.02M4.43M3.56M4.05M4.53M4.33M4.29M3.95M4.66M3.98M3.95M
Dividend Payout Ratio--42.21%-50.32%4.5%----------153.21%305.14%43.2%-